Ordinarily, Tagline doesn’t track drug developments, but rather follows devices and process technologies. But a recent special report in Genetic [MORE]
A group of researchers at the Johns Hopkins Bayview Medical Center Bariatric Surgery Clinic have reported finding a link between [MORE]
Genetic Engineering & Biotechnology News reported recently that GSK’s deal with Actelion, worth almost $3.2 billion, for Actelion’s insomnia drug [MORE]